SAB Biotherapeutics, Inc. (SABS): 8-K filed Jul 7, 2026

Form type

8-K

Filing date

Jul 7, 2026

Accession number

0001193125-26-296936

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)